Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p5
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 5/36)
Character Range: 321513–324685

may cause skin sensitisation to certain individuals. A preliminary test according to the accompanying directions should be made before use;

     written in letters not less than 1.5 mm in height.
    AMINOPYRALID except when included in Schedule 5.
    AMITRAZ.
    AMMONIA (excluding its salts and derivatives other than ammonium hydroxide) except:

       (a) when included in Schedule 5; or

       (b) in preparations for human internal therapeutic use; or

       (c) in preparations for inhalation when absorbed in an inert solid material; or

       (d) in preparations containing 0.5% or less of ammonia.
    AMMONIUM COCOYL ISETHIONATE, except in cosmetic rinse‑off preparations containing 30% or less of ammonium cocoyl isethionate and, if containing more than 5% of ammonium cocoyl isethionate, when labelled with a warning to the following effect:

        IF IN EYES WASH OUT IMMEDIATELY WITH WATER.
    AMMONIUM PERSULFATE in hair preparations.
    ANILINE (excluding its salts and derivatives) except in preparations containing 1% or less of aniline.
    ANTIMONY COMPOUNDS except:

       (a) when included in Schedule 4; or

       (b) antimony chloride in polishes; or

       (c) antimony titanate pigments in paint; or

       (d) in paints or tinters containing 5% or less of antimony calculated on the non‑volatile content of the paint or tinter.
    ARBUTIN (ALPHA) except:

       (a) in preparations for application to the face containing 2% or less alpha‑arbutin with hydroquinone levels of 10mg/kg or less; or

       (b) in preparations for application to the body containing 0.5% or less alpha‑arbutin with hydroquinone levels of 10mg/kg or less.
    ARBUTIN (BETA) except:

       (a) when included in Schedule 4; or

       (b) oral herbal preparations containing 500 mg or less beta‑arbutin per recommended daily dose; or

       (c) in preparations for application to the face containing 7% or less beta‑arbutin with hydroquinone levels of 10mg/kg or less.
    ARBUTIN (DEOXY OR OTHER DERIVATIVES).
    ARSENIC:

       (a) in ant poisons containing 0.4% or less of arsenic; or

       (b) in animal feed premixes containing 4% or less of arsenic; or

       (c) in preparations for the treatment of animals except thiacetarsamide when included in Schedule 4,

     except when separately specified in this Schedule.
    ASPIRIN for the treatment of animals except when included in Schedule 4 or 5.
    AZACONAZOLE except in preparations containing 1% or less of azaconazole.
    AZADIRACHTA INDICA (Neem) including its extracts and derivatives except:

       (a) when included in Schedule 5; or

       (b) in preparations for human internal use; or

       (c) debitterised neem seed oil; or

       (d) in preparations for human dermal therapeutic use containing cold pressed neem seed oil, when in a container fitted with a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (e) in preparations for dermal use containing 1% or less of cold pressed neem seed oil.
    AZAMETHIPHOS.
    AZOBENZENE.
BAMBERMYCIN (flavophospholipol) in animal feed premixes for